which is mixed to form composition together with pharmaceutically acceptable EM- 250 diluent or carrier for local administration in medical treatment of androgen-dependent skin diseases. EFFECT: improved properties of the pharmaceutical composition and more efficient process for medical treatment or prevention of diseases."/> ANTIANDROGENIC COMPOUND, DRUG PRECURSOR, PHARMACEUTICAL COMPOSITIONS, PROCESS FOR MEDICAL TREATMENT OR PREVENTION OF DISEASES
首页> 外国专利> ANTIANDROGENIC COMPOUND, DRUG PRECURSOR, PHARMACEUTICAL COMPOSITIONS, PROCESS FOR MEDICAL TREATMENT OR PREVENTION OF DISEASES

ANTIANDROGENIC COMPOUND, DRUG PRECURSOR, PHARMACEUTICAL COMPOSITIONS, PROCESS FOR MEDICAL TREATMENT OR PREVENTION OF DISEASES

机译:抗雄激素化合物,药物前体,药物成分,药物治疗或疾病预防过程

摘要

FIELD: medicine. SUBSTANCE: claimed invention describes derivatives having androgenic nucleus and specific substituents in R17-position for use as antiantrogens for medical treatment of antirogen- dependent diseases, some preferred embodiments describe compound of formula: which is mixed to form composition together with pharmaceutically acceptable EM- 250 diluent or carrier for local administration in medical treatment of androgen-dependent skin diseases. EFFECT: improved properties of the pharmaceutical composition and more efficient process for medical treatment or prevention of diseases.
机译:领域:医学。物质:要求保护的发明描述了在R 17 位置具有雄激素核和特定取代基的衍生物,用作抗雌激素药,用于治疗依赖于雄激素的疾病,一些优选的实施方案描述了下式的化合物: 00000002.GIF“ he =” 28“ imgContent =” undefined“ imgFormat =” GIF“ wi =” 51“ />,将其与可药用的EM-250稀释剂或载体混合形成组合物,用于雄激素的药物治疗依赖性皮肤疾病。效果:改善了药物组合物的性能,并提高了治疗或预防疾病的效率。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号